Comparison between oral and vaginal administration of misoprostol on uterine contractility

Citation
Kg. Danielsson et al., Comparison between oral and vaginal administration of misoprostol on uterine contractility, OBSTET GYN, 93(2), 1999, pp. 275-280
Citations number
17
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
OBSTETRICS AND GYNECOLOGY
ISSN journal
00297844 → ACNP
Volume
93
Issue
2
Year of publication
1999
Pages
275 - 280
Database
ISI
SICI code
0029-7844(199902)93:2<275:CBOAVA>2.0.ZU;2-Y
Abstract
Objective: To compare the degree of absorption and the effect on uterine co ntractility of the prostaglandin E-1 analogue misoprostol after vaginal and oral administration. Methods: Thirty women with a normal intrauterine pregnancy between 8 and 11 weeks' gestation who requested termination of pregnancy were given either 0.2 mg (orally n = 5; vaginally n = 6) or 0.4 mg (orally n = 10; vaginally n = 9) of misoprostol. Intrauterine pressure was recorded using a Grass pol ygraph connected to a pressure transducer 30 minutes before misoprostol was given and for 4 hours thereafter. At the end of the recording, suction cur ettage was performed. Blood samples were obtained at 0, 0.5, 1, 2, 4, and 6 hours for measurement of misoprostol, which was assayed by high-pressure l iquid chromatography-mass spectrometry. Results: In all patients, the first effect was an increase in uterine tonus . After 0.4 mg of misoprostol administered orally, uterine tonus started to increase after a mean (+/- standard deviation) time of 7.8 +/- 3.0 minutes and reached its maximum after 25.5 +/- 5.0 minutes. The corresponding time s after vaginal administration were 20.9 +/- 5.3 minutes and 46.3 +/- 20.7 minutes, respectively. The initial increase in tonus was also more pronounc ed after oral than after vaginal administration. After vaginal administrati on, all patients developed uterine contractions; the activity, measured in Montevideo units, increased continuously during the observation period. Thi s was not the case after oral administration. Plasma levels of misoprostol were measured in 18 patients. The highest levels were found 30 minutes afte r oral treatment and 1-2 hours after vaginal administration. Conclusion: The long-lasting and continuously increasing uterine contractil ity after vaginal administration can be explained only in part by a direct effect of misoprostol. The longer period of elevated plasma levels of misop rostol may also have initiated the prolonged events leading to increased ut erine contractility. (Obstet Gynecol 1999;93:275-80. (C) 1999 by The Americ an College of Obstetricians and Gynecologists.).